Literature DB >> 21458154

Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer.

Henk G van der Poel1, Tessa Buckle, Oscar R Brouwer, Renato A Valdés Olmos, Fijs W B van Leeuwen.   

Abstract

BACKGROUND: Integration of molecular imaging and in particular intraoperative image guidance is expected to improve the surgical accuracy of laparoscopic lymph node (LN) dissection.
OBJECTIVE: To show the applicability of combining preoperative, intraoperative, and postoperative sentinel node imaging using an integrated diagnostic approach based on an imaging agent that is both radioactive and fluorescent. DESIGN, SETTING, AND PARTICIPANTS: Before surgery, multimodal indocyanine green (ICG)-(99m)Tc-NanoColl was injected into the prostate. Subsequent lymphoscintigraphy and single-photon emission computed tomography/computed tomography (SPECT/CT) imaging of pelvic nodes was performed to determine the location of the sentinel lymph nodes (SLNs) preoperatively. During the surgical procedure a fluorescence laparoscope, optimized for detection in the near infrared range, was used to visualize the nodes identified on SPECT/CT. Eleven patients scheduled for robot-assisted laparoscopic prostatectomy (RALP) with an increased risk of nodal metastasis, based on Memorial Sloan-Kettering Cancer Center/Kattan nomogram estimation, participated in a pilot assessment (N09IGF). SURGICAL PROCEDURE: Patients underwent RALP with LN dissection for prostate cancer. MEASUREMENTS: Radioactive and fluorescent signals were monitored using different modalities, and the correlation between the two types of signals was studied. The location of preoperatively detected SLNs was documented. RESULTS AND LIMITATIONS: Preoperatively, SLNs were identified by SPECT/CT, and the multimodal nature of the imaging agent also enabled intraoperative detection via fluorescence imaging. Fluorescence particularly improved surgical guidance in areas with a high radioactive background signal such as the injection site. Ex vivo analysis revealed a strong correlation between the radioactive and fluorescent content in the excised LNs. Fluorescence detection is limited by the severe tissue attenuation of the signal. Therefore, radio guidance to the areas of interest is still desirable.
CONCLUSIONS: Initial data indicate that multimodal ICG-(99m)Tc-NanoColloid, in combination with a laparoscopic fluorescence laparoscope, can be used to facilitate and optimize dissection of SLNs during RALP procedures.
Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458154     DOI: 10.1016/j.eururo.2011.03.024

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  119 in total

1.  [Radical prostatectomy - pro robotic].

Authors:  R Gillitzer
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

2.  Comment on Heuveling et al.: Nanocolloidal albumin-IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node.

Authors:  Henk G van der Poel; Alfons J M Balm; Omgo E Nieweg; Renato A Valdés Olmos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-24       Impact factor: 9.236

3.  Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model.

Authors:  Sean P Stroup; Christopher J Kane; Salman Farchshchi-Heydari; Claude M James; Christopher H Davis; Anne M Wallace; Carl K Hoh; David R Vera
Journal:  Clin Exp Metastasis       Date:  2012-06-20       Impact factor: 5.150

Review 4.  Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients.

Authors:  Alessandro Conti; Matteo Santoni; Luciano Burattini; Marina Scarpelli; Roberta Mazzucchelli; Andrea B Galosi; Liang Cheng; Antonio Lopez-Beltran; Alberto Briganti; Francesco Montorsi; Rodolfo Montironi
Journal:  World J Urol       Date:  2015-12-22       Impact factor: 4.226

5.  Sentinel lymph node dissection combined with meticulous histology increases the detection rate of nodal metastases in prostate cancer.

Authors:  Michal Staník; Ivo Čapák; Daniel Macík; Jiří Vašina; Eva Lžičařová; Jiří Jarkovský; Martin Šustr; David Miklánek; Jan Doležel
Journal:  Int Urol Nephrol       Date:  2014-03-29       Impact factor: 2.370

Review 6.  Image-guided cancer surgery using near-infrared fluorescence.

Authors:  Alexander L Vahrmeijer; Merlijn Hutteman; Joost R van der Vorst; Cornelis J H van de Velde; John V Frangioni
Journal:  Nat Rev Clin Oncol       Date:  2013-07-23       Impact factor: 66.675

7.  Hexamodal imaging with porphyrin-phospholipid-coated upconversion nanoparticles.

Authors:  James Rieffel; Feng Chen; Jeesu Kim; Guanying Chen; Wei Shao; Shuai Shao; Upendra Chitgupi; Reinier Hernandez; Stephen A Graves; Robert J Nickles; Paras N Prasad; Chulhong Kim; Weibo Cai; Jonathan F Lovell
Journal:  Adv Mater       Date:  2015-01-14       Impact factor: 30.849

8.  Preclinical evaluation of robotic-assisted sentinel lymph node fluorescence imaging.

Authors:  Michael A Liss; Salman Farshchi-Heydari; Zhengtao Qin; Sean A Hickey; David J Hall; Christopher J Kane; David R Vera
Journal:  J Nucl Med       Date:  2014-07-14       Impact factor: 10.057

9.  Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance.

Authors:  Floris P R Verbeek; Quirijn R J G Tummers; Daphne D D Rietbergen; Alexander A W Peters; Boudewijn E Schaafsma; Cornelis J H van de Velde; John V Frangioni; Fijs W B van Leeuwen; Katja N Gaarenstroom; Alexander L Vahrmeijer
Journal:  Int J Gynecol Cancer       Date:  2015-07       Impact factor: 3.437

10.  Anatomical localization of radiocolloid tracer deposition affects outcome of sentinel node procedures in prostate cancer.

Authors:  C M de Korne; E M Wit; J de Jong; R A Valdés Olmos; T Buckle; F W B van Leeuwen; H G van der Poel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-03       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.